Leiden Early Drug Discovery & Development (LED3)
@led3hub.bsky.social did:plc:jnlt3o3km3ebst2vcigkwdch
LED3 is a hub of scientists working on early drug discovery at the Leiden Institute of Chemistry, the Leiden Academic Centre for Drug Research, the Institute of Biology Leiden and the Leiden Institute of Advanced Computer Science. @[email protected]
Bei Bluesky seit
- Follower
- 819
- Folgt
- 42
- Posts
- 231
- Tage in Ranglisten
- 0
Zusammenfassung
Leiden Early Drug Discovery & Development (LED3) (@led3hub.bsky.social) ist seit 19 September 2023 auf Bluesky. Das Konto hat 819 Follower, folgt 42 Konten und hat 231 Posts veröffentlicht.
Ranglisten-Platzierungen
Die besten Tage, an denen Posts dieses Kontos in Debyas Tagesliste kamen.
Dieses Konto war noch in keiner Tagesrangliste.
Zuletzt gelikte Posts
Öffentliche Likes aus dem Bluesky-Netzwerk.
I had an amazing time visiting @yale.edu and presenting some of the work of our group. A huge thank you to @jeanjuchung.bsky.social and Felix Zhu for inviting me and to everyone for the interesting discussions (@craigmcrews.bsky.social, Hongying Shen, Jing Hughes, Yansheng Liu, David Zenisek).
Post anzeigenAnother great LED3 Lecture.
Post anzeigenAmazing @led3hub.bsky.social Lecture by Marc Robillard from Tagworks Pharmaceuticals. He talked about the development of Click-to-Release chemistry and its application to antibody-drug conjugates that can be activated by a chemical trigger. www.nature.com/articles/s42...
Post anzeigen#DrugDiscovery #Click #ClickChemistry #ClickToRelease #ADC #ChemBio #ChemSky #Chemistry
Post anzeigen🔹 Structural Validation: In collaboration with Tessa Gote and @armstrongchembio.bsky.social within our @led3hub.bsky.social, we resolved a crystal structure of the protein in complex with our top hit. This revealed covalent engagement at C111 and key interactions for future optimization. (5/8)
Post anzeigen
Blockierte Konten
Blockierungen sind auf Bluesky öffentlich.
Dieses Konto blockiert niemanden.